Developments in the drug treatment of panic disorder: What is the place of the selective serotonin reuptake inhibitors?

Journal of Affective Disorders

Volumn 40, Issue 1-2, 1996, Pages 85-93

  Westenberg, Herman G M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Drug treatment; Panic disorder; Selective serotonin reuptake inhibitor; Serotonin

Indexed keywords

ALPRAZOLAM; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOMIPRAMINE; FLUVOXAMINE; IMIPRAMINE; PAROXETINE; PHENELZINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; DRUG COMPARISON; HUMAN; PANIC; PRIORITY JOURNAL;

EID: 0030576912     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0327(96)00043-2     Document Type: Article

References (62)

1. Albus, M. and Scheibe, G. (1993) Outcome of panic disorder with or without concomitant depression: a 2-year prospective follow-up study. Am. J. Psychiatry 150, 1878-1880.
2. Alexander, P.E. (1991) Management of panic disorders, J. Psychoactive Drugs 23, 329-333.
3. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (DSM-III). 3rd Edn. American Psychiatric Association, Washington, DC.
4. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). 3rd Edn-Rev. American Psychiatric Association, Washington, DC.
5. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). 4th Edn. American Psychiatric Association, Washington, DC.
6. Angst, J. and Wicki, W. (1993) The epidemiology of frequent and less frequent panic attacks. In: S.A. Montgomery (Ed.), Psychopharmacology of panic. British Association for Psychopharmacology Monograph No. 12, Oxford University Press, Oxford, pp. 7-23.
7. Ballenger, J.C. (1992) Medication discontinuation in panic disorder. J. Clin. Psychiatry 53 (3, Suppl.), 26-31.
8. Ballenger, J.C. (1993) Panic disorder: Efficacy of current treatments. Psychopharmacol. Bull. 29, 477-486.
9. Boyer, W. (1995) Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: A meta-analysis. Int. Clin. Psychopharmacol. 10, 45-49.
10. Bradwejn, J. (1993) Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions. Can. J. Psychiatry 38 (Suppl. 4), S109-S113.
11. Cassano, G.B., Petracca, A., Perugi, G., Nisita, C., Musetti, L., Mengali, F. and McNair, D.M. (1988) Clomipramine for panic disorder. I. The first 10 weeks of a long-term comparison with imipramine, J. Affect. Disord. 14, 123-127.
12. Charney, D.S., Woods, S.W., Goodman, W.K. and Heninger, G.R. (1987) Serotonin function in anxiety II: effects of the serotonin agonist MCPP in panic disorder patients and healthy-subjects. Psychopharmacology 92, 14-24.
13. Cooper, G.L. (1988) The safety of fluoxetine - an update. Br. J. Psychiatry 153 (Suppl.), 77-86.
14. Cox, B.J., Hasey, G., Swinson, R.P., Kuch, K., Cooke, R., Warsh, J. and Jorna, T. (1993) The symptom structure of panic attacks in depressed and anxious patients. Can. J. Psychiatry 38, 181-184.
15. den Boer, J.A. and Westenberg, H.G.M. (1990) Serotonin function in panic disorder: a double-blind placebo-controlled study with fluvoxamine and ritanserin. Psychopharmacology 102, 85-94.
16. den Boer, J.A. and Westenberg, H.G.M. (1991) Do panic attacks reflect an abnormality in serotonin receptor subtypes? Hum. Psychopharmacol. 6, S25-30.
17. den Boer, J.A., Westenberg, H.G.M., Kamerbeek, W.D.J., Verhoeven, W.M.A. and Kahn, R.S. (1987) Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. Int. Clin. Psychopharmacol. 2, 21-32.
18. Doctor, R.M. (1982) Major results of a large-scale pretreatment survey of agoraphobics. In: R.L. DuPont (Ed.), Phobia: A Comprehensive Summary of Modern Treatments. Brunner/Mazel, New York, NY, pp. 203-214.
19. Dunbar, G.C. and Judge, R. (1995) Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Eur. Neuropsychopharmacol. 5, 361 (Abstr. P5-27).
20. Eaton, W.W., Kessler, R.C., Wittchen, H.U. and Magee, W.J. (1994) Panic disorder and panic in the United States. Am. J. Psychiatry 151, 413-420.
21. Evans, L., Kenardy, J., Schneider, P. and Hoey, H. (1986) Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. Acta Psychiatr. Scand. 73, 49-53.
22. Fawcett, J. (1992) Suicide risk factors in depressive disorders and in panic disorder. J. Clin. Psychiatry 53 (3, Suppl.), 9-13.
23. Gloger, S., Grunhaus, L., Birchmacher, B. and Troudart, T. (1981) Treatment of spontaneous panic attacks with clomipramine. Am. J. Psychiatry 138, 1215-1217.
24. Gorman, J.M., Liebowitz, M.R., Fyer A.J., Goetz, D., Campeas, R.B., Fyer, M.R., Davies, S.O. and Klein, D.F. (1987) An open trial of fluoxetine in the treatment of panic attacks. J. Clin. Psychopharmacol. 7, 329-332; J. Clin. Psychopharmacol. 8 (1988) 13 (erratum).
25. Halle, M.T. and Dilsaver, S.C. (1993) Comorbid panic disorder in patients with winter depression. Am. J. Psychiatry 150, 1108-1110.
26. Johnson, J., Weissman, M.M. and Klerman, G.L. (1990) Panic disorder, comorbidity, and suicide attempts. Arch. Gen. Psychiatry 47, 805-808.
27. Johnson, M.R., Lydiard, R.B. and Ballenger, J.C. (1995) Panic disorder. Pathophysiology and drug treatment. Drugs 49, 328-344.
28. Johnston, D.G., Troyer, I.E. and Whitsett S.F. (1988) Clomipramine in the treatment of agoraphobic women. Biol. Psychiatry 25, 101-104.
29. Jonas, J.M. and Cohon, M.S. (1993) A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression; a review of the literature. J. Clin. Psychiatry 54 (10, Suppl.), 25-45.
30. Judge, R. and Dunbar, G.C. (1995) Paroxetine, clomipramine and placebo in the treatment of panic disorder. Eur. Neuropsychopharmacol. 5, 361 (Abs P5-25).
31. Kahn, R.S., Westenberg, H.G., Verhoeven, W.M., Gispen-de Wied, C.C. and Kamerbeck, W.D. (1987) Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int. Clin. Psychopharmacol. 2, 33-45.
32. Kahn, R.S., Wetzler, S., van Praag, H.M., Asnis, G.M. and Strauman, T. (1988) Behavioural indications of serotonergic supersensitivity in patients with panic disorder. Psychiatry Res. 25, 101-104.
33. Kahn, R.S., Wetzler, S., Asnis, G.M. and van Praag, H.M. (1990) The effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology 100, 339-344.
34. Katerndahl, D.A. and Realini, J.P. (1993) Lifetime prevalence of panic states. Am. J. Psychiatry 150, 246-249.
35. Keller, M.B. and Baker, M.A. (1992) The clinical course of panic disorder and depression. J. Clin. Psychiatry 53 (3, Suppl.), 5-8.
36. Keller, M.B. and Hanks, D.L. (1993) Course and outcome in panic disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 17, 551-570.
37. Klein, D.F. and Fink, M. (1962) Psychiatric reaction patterns to imipramine. Am. J. Psychiatry 119, 432-438.
38. Klein, D.F., Coplan, J.D. and Gorman, J.M. (1991) Bases for serotonin related drug use in spontaneous panic behaviour. In: G.B. Cassano and H.S. Akishal (Eds.), Serotonin-related psychiatric syndromes: clinical and therapeutic links. London Royal Society of Medicine Congress and Symposium Series No. 165, pp. 93-97.
39. Klerman, G.L. (1992) Treatments for panic disorder. J. Clin. Psychiatry 53, (3 Suppl.), 14-19.
40. Lipsedge, M.S., Hajioff, J., Muggins, P., Napier, L., Pearce, J., Pike, D.F. and Rich, M. (1973) The management of severe agoraphobia: a comparison of iproniazid and systematic desensitization. Psychopharmalogia 32, 67-80.
41. Maddock, R.J., Carter, C.S., Blacker, K.H., Beitman, B.D., Krishnan, R.R., Jefferson, J.W., Lewis, C.P. and Liebowitz, M.R. (1993) Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia. J. Clin. Psychiatry 54, 88-95.
42. Maier, W. and Lichtermann, D. (1993) The genetic epidemiology of unipolar depression and panic disorder. Int. Clin. Psychopharmacol. 8 (Suppl. 1), 27-33.
43. Markowitz, J.S., Weissman, P.M., Ouellette, R., Lish, J.D. and Klerman, G.L. (1989) Quality of life in panic disorder. Arch. Gen. Psychiatry 46, 984-992.
44. McTavish, D. and Benfield, P. (1990) Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs 39, 136-153.
45. Noyes, R., Clancy, J., Woodman, C., Holt, C.S., Suelzer, M., Christiansen, J. and Anderson, D.J. (1993) Environmental factors related to the outcome of panic disorder. A seven-year follow-up study. J. Nerv. Dis. 181, 529-538.
46. Oehrberg, S. and Christiansen, P. (1995) Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study. Br. J. Psychiatry 167, 374-379.
47. Panic Consensus Statement. Treatment of Panic Disorder, NIH Consensus Development Conference Consensus Statement (1991) National Institutes of Health, Bethesda, MD.
48. Pohl, R., Yeragani, V., Balon, R. and Lycaki, H. (1988) The jitteriness syndrome in panic disorder patients treated with antidepressants. J. Clin. Psychiatry 49, 100-104.
49. Rickels, K., Schweizer, E., Weiss, S. and Zavodnick, S. (1993) Maintenance drug treatment for panic disorder. II. Short-and long-term outcome after drug taper. Arch. Gen. Psychiatry 50, 61-68.
50. Robins, L.N., Helzer, J.E., Weissman, M.M., Orvaschel, H., Gruenberg, E., Burke, J.D. and Regier, D.A. (1984) Lifetime prevalence of specific psychiatric disorders in three sites. Arch. Gen. Psychiatry, 41, 949-958.
51. Salzman, C. (1993) Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse. J. Psychiatric Res. 27 (Suppl. 1), 97-110.
52. Savino, M., Perugi, G., Simonini, E., Soriani, A., Cassano, G.B. and Akiskal, H.S. (1993) Affective comorbidity in panic disorder: Is there a bipolar connection? J. Affect. Disord. 28, 155-163.
53. Schweizer, E., Patterson, W., Rickels, K. and Rosenthal, M. (1993) Double-blind, placebo-controlled study of once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder. Am. J. Psychiatry 150, 1210-1215.
54. Sheehan, D.V., Ballenger, J. and Jacobson, G. (1980) The treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Arch. Gen. Psychiatry 37, 51-59.
55. Sheehan, D.V., Zak, J.P., Miller, J.A. and Fanous, B.S.L. (1988) Panic disorder: The potential role of serotonin reuptake inhibitors. J. Clin. Psychiatry 49 (8, Suppl.), 30-36.
56. Tesar, G.E. and Rosenbaum, J.F. (1993) Recognition and management of panic disorder. Adv. Int. Med. 38, 123-149.
57. Versiani, M., Gentile, V. and Parpocki, J. (1985) Data about 508 cases of panic disorder and responses to treatment with alprazolam, clomipramine, imipramine and tranylcypromine. In: C. Shagass, R.C. Josiassen and W.H. Bridger (Eds.), Biological Psychiatry: Proceedings from the 15th World Congress of Biological Psychiatry. Elsevier Science Publishers, Amsterdam.
58. Volrath, M. and Angst, J. (1989) Outcome of panic and depression in a seven-year follow-up: results of the Zurich study. Acta Psychiatr. Scand. 80, 591-596.
59. Weissman, M.M. (1991) Panic disorder: impact on the quality of life. J. Clin. Psychiatry 52 (2, Suppl.), 6-8.
60. Weissman, M.M., Wickramaratne, P., Adams, P.B., Lish, J.D., Horwath, E., Charney, D., Woods, S.W., Leeman, E. and Frosch, E. (1993) The relationship between panic disorder and major depression. A new family study. Arch. Gen. Psychiatry 50, 767-780.
61. Westenberg, H.G.M. and den Boer, J.A. (1991) Treatment of panic disorder: evidence supporting the role of serotonin. In: C. Idziwoski and P.J. Cowen (Eds.), Serotonin, Sleep and Mental Disorder, Wrightson Biomedical, pp. 147-160.
62. Westenberg, H.G.M. and den Boer, J.A. (1993) New findings in the treatment of panic disorder. Pharmacopsychiatry 26, 30-33.